Minimal change glomerulonephritis following the second dose of the Moderna COVID-19 vaccine

QJM. 2022 Jul 9;115(7):490-491. doi: 10.1093/qjmed/hcac094.
No abstract available

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273
  • COVID-19* / prevention & control
  • Humans
  • Nephrosis, Lipoid*

Substances

  • 2019-nCoV Vaccine mRNA-1273